Work

Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy

Year: 2013

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v122.21.3115.3115

Authors: A Kate Sasser, Tineke Casneuf, Dhammika Amaratunga, Volha Tryputsen, Shaji K Kumar, Vincent Rajkumar, Brett Hall

Institutions: Janssen (Belgium), Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2289972964

FWCI:

Cites:

Cited by: 3

Related to: 10